Technology
Silicon Labs Reports Second Quarter 2026 Results
Published
3 months agoon
By
Wireless IoT leader delivers $228 million in revenue and strong earnings growth
AUSTIN, Texas, Aug. 11, 2026 /PRNewswire/ — Silicon Labs (NASDAQ: SLAB), the leading innovator in low-power wireless, reported financial results for the second quarter, which ended July 4, 2026.
“We delivered revenue of $228 million, continuing our strong sequential and year-over-year growth – a testament to the execution and dedication of the Silicon Labs team,” said Matt Johnson, President and Chief Executive Officer. “Overall profitability improved meaningfully in the quarter, demonstrating the operating leverage inherent in our model. Gross margin was nearly 62%, reflecting the value customers place on our industry-leading solutions.”
Second Quarter Financial Highlights
Revenue was $228 million, up 18% year-over-yearIndustrial & Commercial revenue was $135 million, up 23% year-over-yearHome & Life revenue was $93 million, up 12% year-over-yearBookings and new orders accelerated, while inventory at both our distributors and end customers declinedMedical achieved record revenue in the quarter, up 78% year-over-yearTotal opportunity funnel and design wins both materially accelerated, reinforcing our durable growth trajectoryGAAP diluted loss per share was $(0.32), improving by 52% over the comparable period last yearNon-GAAP diluted earnings per share was $0.71, up 545% over the comparable period last year
Results on a GAAP basis:
GAAP gross margin was 61.6%GAAP operating expenses were $151 millionGAAP operating loss was $11 millionGAAP diluted loss per share was $(0.32)
Results on a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, merger-related costs, and certain other items as set forth in the below GAAP to Non-GAAP reconciliation tables were as follows:
Non-GAAP gross margin was 61.9%Non-GAAP operating expenses were $114 millionNon-GAAP operating income was $27 millionNon-GAAP diluted earnings per share was $0.71
Due to the announced pending acquisition of Silicon Labs by Texas Instruments, Silicon Labs has suspended providing forward-looking guidance.
For more information: Silicon Labs Investor Relations, investor.relations@silabs.com
About Silicon Labs
Silicon Labs (NASDAQ: SLAB) is the leading innovator in low-power wireless connectivity, building embedded technology that connects devices and improves lives. Merging cutting-edge technology into the world’s most highly integrated SoCs, Silicon Labs provides device makers the solutions, support, and ecosystems needed to create advanced edge connectivity applications. Headquartered in Austin, Texas, Silicon Labs has operations in over 16 countries and is the trusted partner for innovative solutions in the smart home, industrial IoT, and smart cities markets. Learn more at silabs.com.
Forward-Looking Statements
This press release contains forward-looking statements regarding Silicon Labs’ current expectations, which are based on its current views and assumptions. The words “believe”, “estimate”, “expect”, “intend”, “anticipate”, “plan”, “project”, “will”, and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements, although the absence of such words does not necessarily mean a statement is not forward looking. These forward-looking statements include, but are not limited to, Silicon Labs’ expectations regarding its near- and long-term strength and durable growth trajectory and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations that are expressed or implied herein. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: our ability to complete the merger with Texas Instruments within the time frame expected, or at all, as well as potential disruptions in our business and restrictions on our activities during the pendency of the merger; fluctuating changes in global trade policies, including the imposition of tariffs, duties, trade sanctions, or other barriers to international commerce; the impact of the current global memory chip shortage; the competitive and cyclical nature of the semiconductor industry; the challenging macroeconomic environment, including disruptions in the financial services industry; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs’ business and results of operations to risks of natural disasters, epidemics or pandemics, war and political unrest; risks that demand and the supply chain may be adversely affected by military conflict (including in the Middle East, and between Russia and Ukraine), terrorism, sanctions or other geopolitical events globally (including in the Middle East, and conflict between Taiwan and China); risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with international activities (including trade barriers, particularly with respect to China); intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing and/or obtaining sufficient supply from Silicon Labs’ distributors, manufacturers and subcontractors; dependence on a limited number of products; absence of long-term commitments from customers; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; dependence on key personnel; stock price volatility; the impact of public health crises on the U.S. and global economy; debt-related risks; capital-raising risks; the timing and scope of share repurchases and/or dividends; average selling prices of products may decrease significantly and rapidly; information technology risks; cyber-attacks against Silicon Labs’ products and its networks; risks associated with any material weakness in our internal controls over financial reporting; risks relating to compliance with laws and regulations; and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.
Note to editors: Silicon Laboratories, Silicon Labs, the “S” symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.
Silicon Laboratories Inc.
Condensed Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
Three Months Ended
Six Months Ended
July 4,
2026
July 5,
2025
July 4,
2026
July 5,
2025
Revenues
$ 228,189
$ 192,845
$ 441,689
$ 370,559
Cost of revenues
87,515
84,736
174,017
164,673
Gross profit
140,674
108,109
267,672
205,886
Operating expenses:
Research and development
95,016
87,821
183,610
176,040
Selling, general and administrative
56,324
43,155
111,810
84,793
Operating expenses
151,340
130,976
295,420
260,833
Operating loss
(10,666)
(22,867)
(27,748)
(54,947)
Other income (expense):
Interest income and other, net
2,489
3,833
6,115
7,626
Interest expense
(251)
(251)
(483)
(535)
Loss before income taxes
(8,428)
(19,285)
(22,116)
(47,856)
Provision for income taxes
2,164
2,532
4,373
4,431
Net loss
$ (10,592)
$ (21,817)
$ (26,489)
$ (52,287)
Loss per share:
Basic
$ (0.32)
$ (0.67)
$ (0.80)
$ (1.61)
Diluted
$ (0.32)
$ (0.67)
$ (0.80)
$ (1.61)
Weighted-average common shares outstanding:
Basic
33,206
32,682
33,084
32,570
Diluted
33,206
32,682
33,084
32,570
Non-GAAP Financial Measurements
In addition to the GAAP results provided throughout this document, Silicon Labs has provided non-GAAP financial measurements on a basis excluding non-cash and other charges and benefits. Details of these excluded items are presented in the tables below, which reconcile the GAAP results to non-GAAP financial measurements.
The non-GAAP financial measurements do not replace the presentation of Silicon Labs’ GAAP financial results. These measurements provide supplemental information to assist management and investors in analyzing Silicon Labs’ financial position and results of operations. Silicon Labs has chosen to provide this information to investors to enable them to perform meaningful comparisons of past, present and future operating results and as a means to emphasize the results of core on-going operations.
Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures
(In thousands, except per share data)
Three Months Ended
July 4, 2026
Non-GAAP Income Statement Items
GAAP
Measure
GAAP
Percent of
Revenue
Stock
Compensation
Expense
Intangible
Asset
Amortization
Merger-
Related Costs
Non-GAAP
Measure
Non-GAAP
Percent of
Revenue
Revenues
$ 228,189
Gross profit
140,674
61.6 %
$ 463
$ —
$ —
$ 141,137
61.9 %
Research and development
95,016
41.6 %
12,902
2,295
3,289
76,530
33.5 %
Selling, general and administrative
56,324
24.7 %
12,284
—
6,258
37,782
16.6 %
Operating expenses
151,340
66.3 %
25,186
2,295
9,547
114,312
50.1 %
Operating income (loss)
(10,666)
(4.7 %)
25,649
2,295
9,547
26,825
11.8 %
Three Months Ended
July 4, 2026
Non-GAAP Earnings (Loss) Per Share
GAAP
Measure
Stock
Compensation
Expense*
Intangible
Asset
Amortization*
Merger-
Related Costs*
Income
Tax
Adjustments**
Non-
GAAP
Measure
Net income (loss)
$ (10,592)
$ 25,649
$ 2,295
$ 9,547
$ (3,067)
$ 23,832
Shares Excluded Due to Net Loss
Diluted shares outstanding
33,206
504
33,710
Diluted earnings (loss) per share
$ (0.32)
$ 0.71
*
Represents pre-tax amounts
**
Represents the application of an 18% non-GAAP tax rate
Silicon Laboratories Inc.
Condensed Consolidated Balance Sheets
(In thousands, except per share data)
(Unaudited)
July 4,
2026
January 3,
2026
Assets
Current assets:
Cash and cash equivalents
$ 362,191
$ 364,222
Short-term investments
35,051
79,400
Accounts receivable, net
79,801
64,513
Inventories
123,340
95,566
Prepaid expenses and other current assets
70,840
70,316
Total current assets
671,223
674,017
Property and equipment, net
130,902
128,643
Goodwill
376,389
376,389
Other intangible assets, net
18,541
23,130
Other assets, net
56,001
67,138
Total assets
$ 1,253,056
$ 1,269,317
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
$ 52,407
$ 50,717
Deferred revenue and returns liability
5,176
5,359
Other current liabilities
66,563
87,711
Total current liabilities
124,146
143,787
Other non-current liabilities
34,108
31,112
Total liabilities
158,254
174,899
Commitments and contingencies
Stockholders’ equity:
Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued
—
—
Common stock – $0.0001 par value; 250,000 shares authorized; 33,366 and 32,955
shares issued and outstanding at July 4, 2026 and January 3, 2026, respectively
3
3
Additional paid-in capital
184,456
157,402
Retained earnings
910,325
936,814
Accumulated other comprehensive income
18
199
Total stockholders’ equity
1,094,802
1,094,418
Total liabilities and stockholders’ equity
$ 1,253,056
$ 1,269,317
Silicon Laboratories Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Six Months Ended
July 4,
2026
July 5,
2025
Operating Activities
Net loss
$ (26,489)
$ (52,287)
Adjustments to reconcile net loss to net cash provided by (used in) operating
activities:
Depreciation of property and equipment
12,171
12,701
Amortization of other intangible assets
4,589
8,780
Stock-based compensation expense
46,704
39,605
Deferred income taxes
1,663
1,504
Changes in operating assets and liabilities:
Accounts receivable
(15,289)
(2,017)
Inventories
(27,734)
24,631
Prepaid expenses and other assets
(803)
5,112
Accounts payable
2,051
12,812
Other current liabilities and income taxes
(7,925)
8,377
Deferred revenue and returns liability
(183)
783
Other non-current liabilities
1,667
(6,965)
Net cash provided by (used in) operating activities
(9,578)
53,036
Investing Activities
Purchases of marketable securities
—
(32,507)
Sales of marketable securities
—
14,986
Maturities of marketable securities
44,119
17,019
Purchases of property and equipment
(22,153)
(13,549)
Proceeds from capital-related government incentives
5,272
—
Net cash provided by (used in) investing activities
27,238
(14,051)
Financing Activities
Payment of taxes withheld for vested stock awards
(27,451)
(13,752)
Proceeds from the issuance of common stock
7,760
7,619
Net cash used in financing activities
(19,691)
(6,133)
Increase (decrease) in cash and cash equivalents
(2,031)
32,852
Cash and cash equivalents at beginning of period
364,222
281,607
Cash and cash equivalents at end of period
$ 362,191
$ 314,459
View original content to download multimedia:https://www.prnewswire.com/news-releases/silicon-labs-reports-second-quarter-2026-results-302848831.html
SOURCE Silicon Labs
You may like
Technology
DentScribe Launches Perio Charting Benchmark and Reports 100% Across All Eight Levels
Published
14 minutes agoon
November 10, 2026By
DentScribe 2.165.0 passed 68 of 68 tests with 1,967 of 1,967 expected entries correct and zero extra entries in the company’s text-to-chart evaluation.
SUNNYVALE, Calif., Nov. 10, 2026 /PRNewswire/ — DentScribe today announced its AI Periodontal Charting Benchmark 1.0 and accompanying performance report, giving dental practices and dental service organizations a practical framework for evaluating AI perio charting. Developed by DentScribe working with teams of dentists, dental hygienists, and dental assistants, the benchmark combines a written charting standard, 68 test scripts, expected charts, and a score card.
In its November 2026 results report, DentScribe reported that it passed all 68 tests across eight levels and handled all 24 tested dictation styles perfectly. All 1,967 expected chart entries were correct, with no extra entries. The results evaluate how the engine converts supplied text into chart entries.
“A hygienist should be able to concentrate on the patient and the probe, not on remembering how a computer wants the findings dictated. We worked with dental teams to make those expectations testable, down to the tooth, site, and reading,” said Dr. Vinni K. Singh, DDS, AFAAID, Founder and CEO of DentScribe.
A Standard for the Chart and a Benchmark for the Software
The charting standard defines the expected interpretation: Universal tooth numbering, six sites per tooth, reading order as the probe travels around the mouth, and rules for missing teeth, corrections, findings, and scope. The benchmark then tests whether software follows those rules. An entry counts as correct only when the value or finding belongs to the right tooth and site. A test passes only when every expected entry is correct and nothing extra appears.
The eight levels progress from individual readings to complete examinations:
Explicit Tooth & Site Charting — Correct placement of named readings, including two-digit pocket depths.Automatic Navigation — Numbers-only dictation, midline direction changes, arch transitions, and missing teeth.Periodontal Findings — Bleeding, suppuration, recession, mucogingival junction measurements, and mobility.Flexible Phrasing & Navigation — Different word orders, findings during probing, jumps, and restatements.The Real Room — Filler words, patient conversation, corrections, and returning to or resuming probing.Accelerated Dictation — Shorthand, scope words, tooth lists, and ranges.Safety — Missing teeth receive no readings, incomplete readings stay incomplete, and findings do not spread to unmentioned sites.Complete Exams: Full Words & Shorthand — Two complete examinations, each expressed both ways, must produce matching charts.
Performance Beyond the Clean Scripts
DentScribe also passed all 13 additional noisy-room text versions, with 471 of 471 expected entries correct and zero extra entries. These scripts contain simulated speech-recognition mishearings; they are not a live suction-noise or microphone study. Across all 81 clean and noisy scripts, eight runs per script produced identical charts.
Both full-word and shorthand versions of each complete exam produced the same expected chart. For the second exam, shorthand reduced the script from 397 words to 210, about 47% fewer words. This measures script length, not demonstrated chairside time savings.
“Accurate transcription is only the beginning. Perio charting must preserve location and context while the clinician changes direction, corrects a reading, or adds a finding on another tooth. Publishing the scripts and expected charts lets customers inspect those behaviors themselves,” said Dr. Ratinder Paul Singh Ahuja, Ph.D., Board Chair of DentScribe.
The benchmark suite reflects styles supported by DentScribe
Evaluate the Charting System in Your Practice
The kit provides read-aloud scripts, expected charts, and a score card. Practices can use the same reader, room, and microphone, score the first attempt, and count extra entries separately. The kit and performance report are available from DentScribe.
Book a benchmark demonstration: https://www.dentscribe.ai/book-a-demo
About DentScribe
DentScribe is an AI platform for dental documentation and practice intelligence. Founded by practicing dentist Dr. Vinni K. Singh, it combines dental SOAP notes and voice perio charting with DentScribe CoPilot, DentScribe GPS (Guided Production System), after-care summaries, specialist reports, and treatment coordinator notes. Its practice management integrations include Dentrix, Open Dental, and Eaglesoft. DentScribe helps teams complete documentation and act on information already present in the clinical record.
Media Contact
DentScribe Communications
hello@dentscribe.ai | +1 650 446 6161
710 Lakeway Drive, Suite 200, Sunnyvale, CA 94085
View original content to download multimedia:https://www.prnewswire.com/news-releases/dentscribe-launches-perio-charting-benchmark-and-reports-100-across-all-eight-levels-302934348.html
SOURCE DentScribe
Technology
CURE International completes electronic medical records rollout across its eight children’s hospitals with Thoughtworks
Published
14 minutes agoon
November 10, 2026By
BENGALURU, India, Nov. 10, 2026 /PRNewswire/ — Thoughtworks, a global technology consultancy integrating design, engineering and AI to drive digital innovation, worked with CURE International (CURE), a global non-profit, to move clinical records at all their pediatric hospitals from paper to a modern electronic medical records (EMR) system. CURE provides surgical care at no cost to children with treatable disabilities and their hospitals, seven across Africa and one in the Philippines, now run on Bahmni, an open-source hospital management system incubated by Thoughtworks for low-resource settings.
Much of the clinical work in CURE’s hospitals used to run on paper, with notes written by hand, carried between departments and re-entered later. Each hospital also has its own specialties, infrastructure and staffing.
Thoughtworks worked with the non-profit to modernize and standardize their systems to digitally document all their patient clinical care journeys. The partners customized and deployed Bahmni across CURE’s network.
The latest rollout builds on a partnership that began in 2023, when CURE first engaged Thoughtworks to digitize care in its children’s hospitals. Thoughtworks’ Managed Services team continues to run deployments and day-to-day operations across the network.
“Taking eight hospitals from paper to digital without interrupting care is a monumental challenge,” said Kevin de Smidt, Chief Technology Officer at CURE International. “The Thoughtworks team learned how our clinicians actually work, allowing us to roll out a system that lets our teams spend less time chasing paperwork and more time focused on providing world-class surgical care to the children we serve. Because we built this on Bahmni, these EMR enhancements are going back into the open-source project, ensuring the next low-resource hospital starts further ahead than we did.”
To give clinicians reliable digital tools in every hospital, the work focused on four priority areas:
Safer clinical care: Adding high-visibility alerts for allergies and the need for blood crossmatching, supervisor approval for changes to medication records, dosing guidance linked to each child’s weight and a new variable dose protocol.Less administrative work on the ward: Introducing electronic drug charts, automated nursing tasks and ward-level inpatient dashboards. A routine medication round now takes three clicks instead of seven.Better use of operating theaters: Tracking each patient’s surgical readiness in real time and suggesting a replacement patient when a scheduled surgery can’t go ahead.Reliable operations without disrupting care: Upgrading the platform that helped deployments reach each site 60% faster and causing 45% less disruption to patient services.
“Executing a multi-region clinical rollout across eight global hospitals demands absolute operational resilience,” said Steve Obana, Senior Vice President – Life Sciences & MedTech at Thoughtworks. “Healthcare platforms operating in these environments cannot afford downtime or instability. Our team approached this with rigorous engineering discipline and we are proud to provide the managed services backbone and technical stability that allows CURE’s medical teams to scale their life-changing work with absolute confidence in their systems.”
CURE has extended its managed services support with Thoughtworks for a further year, covering platform upgrades, stability and operations across all eight hospitals.
Features built for CURE, including inpatient care and monitoring and a digital medication administration record, are being contributed back to the core Bahmni project. This makes them available to other hospitals deploying the platform in low-resource settings.
By combining its experience building Bahmni with managed services operations, Thoughtworks is helping CURE International deliver technology that works where it matters most: giving clinicians reliable tools and information to provide safe, effective care for every child.
Supporting resources:
Read the CURE International client story.Learn more about Bahmni.Explore Thoughtworks’ work in healthcare and managed services.Follow Thoughtworks on X, LinkedIn, and YouTube.
About CURE International
CURE International is a Christian nonprofit organization operating a global network of eight children’s hospitals that offer no-cost surgical interventions for children living with treatable disabilities. CURE hospitals provide life-changing care for children suffering from conditions such as cleft lip/palate, neglected clubfoot, bowed legs, burn contractures, spina bifida, brain tumors, and hydrocephalus. In addition to world-class clinical service, CURE ministers to the emotional and spiritual needs of patients and their communities. Since its first hospital opened in 1998, CURE has completed more than 5.7 million patient visits and over 400,000 life-changing surgeries.
For more information, visit https://cure.org
About Thoughtworks
Thoughtworks is a global technology consultancy that integrates design, engineering and AI to drive digital innovation. We are over 10,000 people strong across 47 offices in 18 countries. For 30-plus years, we’ve delivered extraordinary impact together with our clients by helping them solve complex business problems with technology and culture as the differentiator.
Media contacts:
For CURE International
Gary Weyel
Marketing Director
gary.weyel@cureinternational.org
For Thoughtworks:
Michelle Surendran
Head of Public Relations for APAC and India
michels@thoughtworks.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/cure-international-completes-electronic-medical-records-rollout-across-its-eight-childrens-hospitals-with-thoughtworks-302933263.html
SOURCE Thoughtworks
Technology
Hong Kong Web3 Festival 2027 Announces “OnChain Finance” Theme, Introduces Institutional Arena
Published
14 minutes agoon
November 10, 2026By
Hong Kong Web3 Festival 2027 will focus on “OnChain Finance” and introduce its inaugural Institutional Arena, an invitation-only, closed-door program bringing together senior executives and decision-makers from global financial institutions and the digital asset industry to explore developments in on-chain finance and opportunities for institutional collaboration.
HONG KONG, Nov. 10, 2026 /PRNewswire/ — The fifth edition of Hong Kong Web3 Festival, co-hosted by Wanxiang Blockchain Labs and HashKey Group and organized by W3ME, will take place from April 19 to 21, 2027, at the Hong Kong Convention and Exhibition Centre (HKCEC). Under the theme “OnChain Finance”, this year’s Festival will introduce its inaugural Institutional Arena, a fully closed-door, invitation-only program bringing together senior executives and key decision-makers from global banks, securities firms, asset managers, payment providers, insurance companies, family offices, and the digital asset industry to examine opportunities and future developments in on-chain finance.
As asset tokenization moves toward real-world adoption, stablecoin payments and on-chain settlement are expanding into a broader range of financial applications. Blockchain technology is becoming increasingly integrated into core financial market activities, including asset issuance, trading, payments, and settlement. Meanwhile, banks, asset managers, and payment companies worldwide are accelerating their engagement with digital assets, bringing greater attention to the integration of on-chain and traditional financial systems, cross-market collaboration, and regulatory compliance. From financial product innovation to the evolution of market mechanisms and infrastructure, OnChain Finance is driving deeper integration between blockchain technology and traditional finance.
Since its inaugural edition in 2023, Hong Kong Web3 Festival has witnessed the digital asset industry’s shift from infrastructure exploration toward practical applications, alongside growing engagement between traditional financial institutions and the digital asset sector. Previous editions have featured Cathie Wood, CEO and CIO of ARK Invest, sharing perspectives on digital assets and investment trends, as well as representatives from Hong Kong Exchanges and Clearing (HKEX), WeBank, and Ant International discussing financial technology innovation and real-world applications. Financial institutions including BlackRock, HSBC, China International Capital Corporation (CICC), and China Asset Management (Hong Kong) have also participated in industry discussions, reflecting the Festival’s continued engagement across banking, securities, asset management, investment, and financial technology.
Entering its fifth year, Hong Kong Web3 Festival 2027 will build on its longstanding focus on blockchain innovation and next-generation financial infrastructure, with OnChain Finance as its annual theme. The Festival will explore key topics including asset tokenization, stablecoins and global payments, on-chain capital markets, institutional digital asset services, regulatory compliance, quantum computing and cryptography, AI and financial security, as well as open hardware and privacy protection. Bringing together financial institutions, technology companies, and digital asset industry representatives from around the world, the Festival will examine practical applications, market opportunities, and future developments in on-chain finance.
Institutional Arena to Bring Global Financial Leaders Together for Closed-Door Discussions
A major new addition to the 2027 Festival, the Institutional Arena will be held during the three-day event from April 19 to 21. Operating on a fully closed-door, invitation-only basis, it will bring together senior executives and key decision-makers from global banks, asset management firms, payment companies, institutional investors, and digital asset businesses. The program is designed to provide a more focused and specialized setting for institutional engagement, while offering dedicated venues for leading financial institutions to host their own closed-door events.
As a key addition to this year’s program, the Institutional Arena will feature a dedicated networking area for institutional participants. Through keynote presentations, closed-door roundtables, and thematic discussions, it will address issues of particular interest to financial institutions, examining business practices across different markets and opportunities for collaboration. The program will also create a more targeted environment for direct engagement among financial institutions and between these institutions and innovative companies across the industry.
Complementing the Festival’s broader industry discussions, the Institutional Arena will provide a dedicated setting for deeper dialogue on practical business priorities, facilitating cross-institutional collaboration and business connections between global financial institutions and the digital asset sector.
Four Editions of Global Industry Engagement
Since its launch in 2023, Hong Kong Web3 Festival has grown into an international platform connecting participants across digital assets, finance, and technology. Across its first four editions, the festival has attracted more than 150,000 attendees, featured over 1,600 speakers, hosted more than 500 exhibitors, and supported over 600 side events.
Building on four editions of engagement spanning technological innovation and financial applications, Hong Kong Web3 Festival 2027 will place OnChain Finance at the center of its program. With the introduction of the Institutional Arena, the Festival aims to strengthen connections between global financial institutions and the digital asset industry, bringing together forward-looking perspectives and practical developments in financial innovation.
Further details on the Festival agenda, speakers, and Institutional Arena arrangements will be announced in due course. Follow the Wanxiang Blockchain Labs official WeChat account and Hong Kong Web3 Festival’s official X account (@festival_web3) for the latest updates.
Partnership and Participation Opportunities
Sponsorship Opportunities: https://hongkong.web3festival.org/2027sponsorshipApply to Speak: https://hongkong.web3festival.org/2027speakerapplicationMedia & Community Partnerships: https://hongkong.web3festival.org/2027partnerSide Event Applications: https://hongkong.web3festival.org/2027sideeventContact: w3@blockchainlabs.org
About Wanxiang Blockchain Labs
Founded in 2015, Wanxiang Blockchain Labs (the “Labs”) is a non-profit research institution dedicated to blockchain technology research and development. It brings together experts from around the world to advance research, foster dialogue, and explore the development, applications, and strategic implications of blockchain technology. Through its research and initiatives, the Labs seeks to provide insights and guidance for entrepreneurs, inform regulatory discussions, and support the broader development of blockchain technology and its potential contributions to society and the economy.
Since its establishment, the Labs has built an international presence through initiatives including the annual Shanghai Blockchain Global Summit and Hong Kong Web3 Festival, as well as hackathons, developer programs, incubation initiatives, blockchain publications, research projects, lectures, and academic collaborations.
About HashKey Group (3887.HK)
HashKey Group (3887.HK) is a leading digital asset financial services group in Asia with a global footprint. Founded in 2018, we are building the next-generation global financial infrastructure to serve institutions, retail investors and blockchain ecosystem partners. We enable traditional institutions and blockchain projects to efficiently access global resources and achieve compliant expansion and growth for their products and businesses. The Group operates across four core pillars: Transaction Facilitation, On-Chain Services, Asset Management and RWA Tokenisation.
HashKey Group is committed to driving the large-scale adoption of blockchain technology and delivering dependable and accessible digital asset services to one billion users worldwide.
View original content:https://www.prnewswire.com/apac/news-releases/hong-kong-web3-festival-2027-announces-onchain-finance-theme-introduces-institutional-arena-302934392.html
SOURCE Hong Kong Web3 Festival
DentScribe Launches Perio Charting Benchmark and Reports 100% Across All Eight Levels
CURE International completes electronic medical records rollout across its eight children’s hospitals with Thoughtworks
Hong Kong Web3 Festival 2027 Announces “OnChain Finance” Theme, Introduces Institutional Arena
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology4 days agoDiamond Foundry Announces First-Ever D200mm Single-Crystal Diamond
-
Coin Market4 days agoCrypto exchanges tout cold storage ratios after Binance attack
-
Near Videos5 days agoWhere AI money lands in crypto
-
Technology4 days ago2026 World Internet Conference Wuzhen Summit Opens
-
Technology4 days agoASTRI Establishes Advisory Board for Smart Mobility Technology Alliance
-
Technology5 days agoOpenAssets and Digital Asset Partner to Modernize Capital Markets Infrastructure
-
Technology5 days agoFinshape launches Agentic DBOS: agentic AI already supporting digital banking projects
-
Coin Market4 days agoBitcoin, Ether ETFs post $530M outflows as election gains evaporate
